U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma
CLINICAL CANCER RESEARCH(2013)
关键词
Basal Cell Carcinoma
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL CANCER RESEARCH(2013)